The First CRISPR Therapy Approved in the U.S. Will Treat Sickle Cell Disease

Kerry Morrone, M.D., talks about the benefits of a new CRISPR treatment for sickle-cell disease and the importance of ensuring health equity for patients around the world who need treatment and care. Dr. Morrone is assistant professor of pediatrics at Einstein and director of the Sickle-Cell Program at the Children's Hospital at Montefiore.


Sickle-Cell Disease

Kerry Morrone, M.D., discusses the signs and symptoms of sickle-cell disease, complications patients may experience, and current treatments. Dr. Morrone is assistant professor of pediatrics at Einstein and director of the Sickle-Cell Program at the Children's Hospital at Montefiore.